Objective: To investigate the effects of platelet rich plasma (PRP) and fibrin sealant (FS) on facial nerve regeneration. Study Design: Prospective, randomized, and controlled animal study. Methods: Experiments involved the transection and repair of facial nerve of 49 male adult rats. Seven groups were created dependant on the method of repair: suture; PRP (with/without suture); platelet poor plasma (PPP) (with/without suture); and FS (with/without suture) groups. Each method of repair was applied immediately after the nerve transection. The outcomes measured were: 1) observation of gross recovery of vibrissae movements within 8-week period after nerve transection and repair using a 5-point scale and comparing the left (test) side with the right (control) side; 2) comparisons of facial nerve motor action potentials (MAP) recorded before and 8 weeks after nerve transection and repair, including both the transected and control (untreated) nerves; 3) histologic evaluation of axons counts and the area of the axons. Results: Vibrissae movement observation: the inclusion of suturing resulted in overall improved outcomes. This was found for comparisons of the suture group with PRP group; PRP with/without suture groups; and PPP with/without suture groups (P < .05). The PRP without suture group had a significantly greater degree of recovery than the PPP without suture group (P < .05), but it did not have better performance than suture group (P > .05). The movement recovery of the suture group was significantly better than the FS group (P ‫؍‬ .014). The recovery of function of the PRP groups was better than that of the FS groups, although this did not reach statistical significance (P ‫؍‬ .09). Electrophysiologic testing: there was a significantly better performance of the suture group when compared with the PRP and PPP without suture groups in nerve conduction velocity (P < .05). The PRP with suture group had the best results when compared with the suture as well as the PPP with suture groups in duration and latency-2 of MAP (P < .05). For the FS groups, no results were found demonstrating a biological effect. The PRP with suture group demonstrated the best performance in the latency-2 and the area under the curve of MAP when compared with the suture and FS with suture groups (P < .05). Histomorphometric analysis: PRP with suture demonstrated the greatest increase in axon counts when compared with suture, FS with suture, and PPP with suture groups (P < .05). There was no statistically significant difference seen in axon diameter. Conclusion: The best results for the return of function in our rat facial nerve axotomy models occurred when the nerve ends were sutured together. At the same time, the data demonstrated a measurable neurotrophic effect when PRP was present, with the most favorable results seen with PRP added to suture. There was an improved functional outcome with the use of PRP in comparison with FS or no bioactive agents (PPP). FS showed no benefit over conventional suturing in facial nerve regeneration. Our study provides the potential of a new clinical application for PRP in peripheral nerve regeneration.
INTRODUCTION
Peripheral facial nerve palsy is a devastating condition. Restoration of function after transection of the facial nerve is poor, and occurrence of postparalytic sequelae is inevitable. 1, 2 Although epineural and fascicular suturing are the most widely used techniques for its repair, 3 there is a great deal of research being performed to search for improved techniques to enhance regeneration of injured facial nerve. 4 Platelet rich plasma (PRP) is prepared by centrifugation of the patient's own blood. 5 Platelets contain various growth factors such as platelet-derived growth factor (PDGF), transforming growth factor-␤, and vascular endothelial growth factor. 5 When platelets are activated, they release these factors, which play important biological roles in various conditions. 6 It has been demonstrated that neurons express PDGF receptors 7 and that PDGF-␤ has been proven to be a mitogen and survival factor for Schwann cells with a trophic activity on neurons. Also, an augmented PDGF-␤ expression in peripheral neurons has been found after peripheral nerve injury, 8 suggesting a role in peripheral nerve regeneration. These findings have led some authors to investigate the effects of PDGF, which has been found to improve regeneration and remyelination of the nervous system. 9 Moreover, plasma, enriched with platelets provides a medium that allows for coagulation. The adhesive effect of this coagulation enabled the use of PRP intraoperatively to help prevent or decrease surgical bleeding. 10, 11 It is therefore hypothesized that the application of PRP to the transected peripheral nerve could better coapt the nerve ends, and at the same time, it provides the nerve with a medium enriched with platelet growth factors to improve regeneration.
In addition, fibrin sealant (FS) has been used for nerve repair. All preparations of FS mimic the final common pathway of the coagulation cascade in which fibrinogen is converted to fibrin in the presence of thrombin and calcium. 12, 13 There is debate in the literature with regard to the effect of FS on peripheral nerve regeneration. Some authors report better results than suturing after transection of peripheral nerves. 4, 13 In contrast, others report better results with suturing than FS 3 or no appreciable difference between the two techniques. 14 Studies exist comparing the effects of FS and PRP, primarily in oral and maxillofacial surgery. 11 In the current study, we report our findings on the effects of PRP and FS on facial nerve regeneration after its transection in a rat model.
METHODS
Approval for performing this study was obtained from the institutional animal care and use committee.
Animals
Experiments were carried out on 49 male Sprague-Dauley rats weighing 250 to 300 g.
Surgical Techniques
All rats underwent two procedures: first, a survival surgery (left side) and second, a nonsurvival surgery (right and left sides), performed 8 weeks after the first surgery. All surgical procedures were performed under aseptic conditions. Rats were anesthetized with xylazine hydrochloride (3 mg/kg) and ketamine hydrochloride (100 mg/kg) by intramuscular injection. The microsurgical techniques were performed using a Zeiss operating microscope (Carl Zeiss, Inc., Thornwood, NY). In the first surgery, the left facial nerve trunk was exposed and transected midway between the point of its exit from the stylomastoid foramen and the point of its bifurcation, and then it was followed by immediate reanastomosis. The animals were categorized into four main groups according to the method of re-anastomosis:
• Suture: 11 rats, using 2 perineural 9 -0 microsutures (Ethicon Inc, Somerville, NJ); • PRP: 10 rats, (a) without suturing, 5 rats; (b) with suturing, 5 rats. There is decreased amplitude (bottom, represented by horizontal markers) and a prolonged initial latency period (until first vertical marker). Distances between stimulating and recording electrodes were provided to program to calculate conduction velocity. • Platelet poor plasma (PPP): 10 rats, (a) without suturing, 5 rats; (b) with suturing, 5 rats.
• FS: 18 rats, (a) without suturing, 12 rats; (b) with suturing, 6 rats.
The muscle layers and skin were closed with 6 -0 silk sutures. After an 8-week interval, the second (nonsurvival) surgery was performed (right and left sides).
PRP and PPP Preparation
PRP and PPP were obtained through a simplified closed centrifugation system (Magellan Autologous Platelet Separator, Medtronics, Inc., Minneapolis, MN), which uses autologous anticoagulated blood. Six rats were killed to obtain the rat blood. Each cycle required 30 mL of blood, and PRP or PPP were separated by the system. The device had a special software program to process rat blood.
FS Preparation
A commercial FS was used for nerve re-anastomosis in the FS group (Tisseel-VH, Two-component, Vapor heated Fibrin Sealant Kit, Baxter Health Care, Westlake Village, CA): • The fibrinogen concentration is 30 times that of human blood, and it reproduces the last steps of the coagulation cascade (conversion of fibrinogen to fibrin).
• The contents are combined by using a double-syringe application system, with application then to the surgical field.
An amount of 0.3 to 0.5 mL from PRP, PPP, or FS was then applied to the equivalent group immediately after transection in between the two ends of the transected nerve while holding the perineurium of the nerve ends for an appropriate time before wound closure (3-5 min). Application of PRP, PPP, or FS was through double-syringe application system.
Methods of Functional Outcomes Evaluation
Subjective vibrissae movement observation.
The left-sided movements were assessed in comparison with the right side using a 5-point scale: 0 ϭ no movement, 1 ϭ barely detectable movement, 2 ϭ less significant movement, 3 ϭ significant but asymmetric movement, and 4 ϭ symmetric movement. Observed movement was recorded twice weekly for 8 weeks after the initial nerve transection and repair.
At the end of the 8-week period, the number of rats in each treatment group for each rating was counted and compared using Fisher's exact test. Additional two-group and three-group comparisons based on specific hypotheses were also performed using Fisher's exact test.
Electrophysiologic testing.
Electromyography recordings performed before axotomy (on left side) and again 8 weeks after axotomy (on right "control" side and posttreatment on left sides). The rats were anesthetized, and the compound motor action potentials (MAPs) of the vibrissal pads were recorded by two monopolar needle electrodes inserted subcutaneously at symmetric points in the vibrissal array. The main trunk of the facial nerve was exposed and stimulated with a single electrode with a rectangular current pulse of 0.05 ms duration delivered from a VikingQuest Portable 2-channel (Fig. 1) . Pretreatment recordings for the experimental (left) side pretreatment were summarized by treatment group as medians and ranges and compared across treatment groups. Difference in scores of posttreatment minus pretreatment for the experimental side and also posttreatment for the experimental side minus the control (right) side were calculated and summarized with medians and ranges. Comparisons were made across all treatment groups using the nonparametric Kruskal-Wallis test. The suture only group was considered as a control treatment (standard of care), and pair-wise comparisons were made for each of the other treatment groups with the suture only group using the Wilcoxon two-sample test. Additional two-group and three-group comparisons based on specific hypotheses were also performed using the appropriate nonparametric test.
Histomorphometric analysis.
Sacrifice was performed at the end of the end of the 8 week period after the first surgery, and samples of facial nerve were obtained. Two to 3 mm samples were obtained from the main trunk of both sides at equivalent points, which was distal to the site of transection. Fixation of the nerve biopsies was performed in 2% osmium tetroxide ϩ 3% glut/4% paraformald at pH 7.4 for 2 hours. The nerve was dehydrated and embedded in plastic (dodecenyl succinic anhydride and nadic methyl anhydride). Cross sections of 1 m thickness were prepared, stained with toluidine blue, and examined by light microscopy. The histologic analysis of the facial nerve was performed digitally, and the axons were counted and measured at a final magnification of ϫ100 using a Nikon (Tokyo, Japan) camera with UPLAN oil immersion objective. The observer was blinded in this evaluation of the different groups. Axon counts and the average area of the individual axons were provided through software programs (Stereo Investigator and Neuro Explorer, MicroBright Field, Inc., Williston, VT, U.S.A.) (Fig. 2) . In this system, a two-dimensional stereologic principle is used for the axons counts: an optical fractionater, a sampling procedure that allows all axons to be equally represented. We have also used unbiased sampling sites for the morphometric analysis of the individual axons.
Results of the axons counts and the area of axons were summarized as medians and ranges. Difference in scores of control (right) side minus test (left) side were compared across all treatment groups using a nonparametric Kruskal-Wallis test. In addition, the pair-wise comparisons were made for each of the other treatment groups to the suture only group using the Wil- 
RESULTS

Vibrissae Movement Observation
Time to onset of recovery. The PPP without suture group was the slowest group to demonstrate recovery of movement after transection and re-anastomosis. The suture groups, as well as the PRP and suture groups, were the earliest groups to start recovery (Fig. 3A) .
Final recovery (after 8 wk).
• PRP: inclusion of suturing resulted in an overall improved outcomes; this was in comparison with the following groups: 1) suture versus PRP without suture groups (P Ͻ .05); 2) PRP with suture versus PRP groups (P Ͻ .05); 3) PPP with suture versus PPP without suture groups (P Ͻ .05). The PRP with suture group did not have better performance compared with the suture group (P Ͼ .05). In addition, the PRP without suture group had a significantly better recovery than the PPP without suture group (P Ͻ .05).
• FS: the suture group had a significantly better recovery than the FS without suture group (P Ͻ .05).
• PRP versus FS: recovery of function of the PRP without suture group was better than the FS without suture group, although this did not reach statistical significance (P Ͻ .1) (Table I) (Fig. 3B) .
Electrophysiologic testing.
Initial recordings were obtained on the left (transected) side of each rat pre-axotomy (pretreatment). The median in the recorded values for latencies, duration, amplitude, area, and conduction velocity were compared between the groups. There was no statistically significant differences in the comparisons across the groups in their pre-axotomy recordings (P Ͼ .05).
After 8 weeks, recordings were obtained on the treated left (transected) side and the untreated right (control or nontransected) side, where differences between left and right sides were calculated. In addition, pre-and posttreatment recordings on the left side were also calculated. Recordings were then compared across the different groups.
• PRP, evaluation of the "adhesive" effect of PRP:
there was a significantly better performance of the suture group when compared with the PRP and PPP without suture groups in nerve conduction velocity (P Ͻ .05); also, the PPP only group had the worst performance (Table II) (Fig. 4 ).
• PRP, evaluation of the "neurotrophic" effect of PRP: the PRP with suture group had the best results compared with the suture and PPP with suture groups in duration and latency-2 of MAP (P Ͻ .05), (Table III) (Fig. 5 ).
• FS: the only parameter that met statistical significance in which the FS with suture group had better performance than the FS only group was the area under the curve of MAP in comparing the difference between the posttreatment recordings of the left and right sides (P Ͻ .05) (Table IV) (Fig. 6 ).
• PRP versus FS: the PRP with suture group significantly had the best performance in latency-2 and area under the curve of the action potentials when compared with the suture and FS with suture groups (P Ͻ .05) ( Table V) (Fig. 7) .
Histomorphometric analysis.
• PRP: the PRP and suture group demonstrated the greatest increase in the axon counts after treatment when compared with the suture and the PPP with suture groups (P Ͻ .05) (Table VI) (Fig. 8A ).
• FS: the histomorphometric analysis did not demonstrate any statistically significant findings in comparing the FS, FS with suture, and suture groups.
• PRP versus FS: the PRP with suture group demonstrated the greatest increase in the axon counts after treatment when compared with the suture and the FS with suture groups (P Ͻ .05) (Table VII) (Fig. 8B ).
DISCUSSION
The obstacles to successful facial reanimation after transection are formidable. Although repair of the injured nerve is often possible with a microsurgical technique, the results are typically disappointing. The reasons for this are complex. On the one hand, the effectiveness of axonal regeneration is often poor. On the other hand, synkinesis, the aberrant regeneration with subsequent disordered movement, inevitably occurs with significant regeneration. Progress in this regard will require more effective regeneration. Not only will axonal regeneration need to be enhanced, but this process will also need to be more accurate as well. This study was intended to investigate just one component of such a strategy, which is the potential for increasing axonal regeneration through the application of readily available, autogenous growth factors.
Our results demonstrate a measurable neurotrophic effect of PRP on facial nerve regeneration after transection in a rat model. This was particularly true when the PRP was used in conjunction with conventional suturing. This is based on the statistically significant results that we found when transected facial nerve was treated with PRP with suture: 1): vibrissae movement evaluation of this group demonstrated a more rapid recovery; 2) electrophysiologic testing of this group demonstrated that its MAP had the lowest prolongation of latency-2 after treatment; and 3) histologic evaluation of this group demonstrated the greatest increase in the axon counts after treatment. These findings are supported by previous studies that documented a neurotrophic effect of platelet growth factors on neurons. 7, 8 It is also to be noted that we evaluated outcomes in our facial nerve rat model after 8 weeks from transection and repair, which has been demonstrated to be optimal to obtain successful results. 15 The results for the group with suture and PRP were superior to the PRP without suture group. The adhesive effect of PRP does not appear to be sufficient for facial nerve repair after transection. It was noted on the surgical exploration of transection sites that the groups with PRP without suture often demonstrated poor coaptation and nerve end alignment. The meticulous coaptation of the nerve ends is critical to good outcomes, and the PRP without suture did not appear to accomplish this to an acceptable level. At the same time, the superior results of the PRP without suture when compared with the PPP without suture groups that were consistently demonstrated in our study demonstrate the neurotrophic value of PRP in improving the functional outcome of facial nerve regeneration.
Enhanced myelination has been seen in previous studies in response to exposure to PDGF. Neurons and Schwann cells express PDGF and PDGF-␤ receptors. 7, 9 We evaluated this qualitatively. The groups that underwent suture repair appeared to demonstrate increased myelination in comparison with those that did not. This was particularly true for the groups treated with PRP, especially when combined with suture (Fig. 9) .
FS is quick to prepare and easy to apply in reuniting nerve ends in narrow areas difficult to be accessed through traditional sutures (as in intrapetrous anastomosis of facial nerve). 13 We found no significant effect of FS on nerve regeneration; a finding that is consistent with some previous work. 14 The PRP groups demonstrated better outcomes than the FS groups.
Previous studies that reported a neurotrophic effect of PDGFs on peripheral nerve regeneration used human recombinant commercial products; on the contrary, our findings demonstrated a cost-effective, easy, and quick preparation of PRP. This preparation uses the subject's own blood to safely provide autologous PRP. Although much is yet to be determined, our study provided the potential of a new clinical application of PRP.
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